IL6 and coronary artery disorder: Prolonged exposure to pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) may lead to accelerated vascular damage and plaque instability, increasing CHD risk over time.